Camilla Simpson
Direktor/Vorstandsmitglied bei SPRUCE BIOSCIENCES, INC.
Vermögen: - $ am 30.04.2024
Profil
Ms. Camilla V.
Simpson is an Independent Director at GRI Bio, Inc., a President & Managing Member at Rare Strategic LLC, an Independent Director at Spruce Biosciences, Inc. and a Chief Executive Officer & Director at Zehna Therapeutics, Inc. She is on the Board of Directors at GRI Bio, Inc., Dyve Biosciences, Inc., Aristea Therapeutics, Inc., Spruce Biosciences, Inc. and Zehna Therapeutics, Inc. Ms. Simpson was previously employed as a Senior VP & Head-Product Portfolio Development by BioMarin Pharmaceutical, Inc. and a VP-Regulatory Affairs & Business Development by Shire Pharmaceuticals, Inc. She also served on the board at Vallon Pharmaceuticals, Inc. She received her undergraduate degree from Kingston University, an undergraduate degree from National University of Ireland Galway and a graduate degree from the University of London.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SPRUCE BIOSCIENCES, INC.
-.--% | 25.03.2024 | 0 ( -.--% ) | - $ | 30.04.2024 |
GRI BIO, INC.
-.--% | 31.12.2023 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Camilla Simpson
| Unternehmen | Position | Beginn |
|---|---|---|
| SPRUCE BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 13.11.2017 |
| GRI BIO, INC. | Direktor/Vorstandsmitglied | 24.04.2023 |
| Rare Strategic LLC | Gründer | 01.04.2019 |
Dyve Biosciences, Inc.
 Dyve Biosciences, Inc. BiotechnologyHealth Technology Dyve Biosciences, Inc. operates as a research and development company. It focuses on biotech that creates novel therapeutics using proprietary science. The company was founded by Ryan Beal and Rajit Malhotra and is headquartered in Thousand Oaks, CA. | Direktor/Vorstandsmitglied | 01.12.2020 |
Aristea Therapeutics, Inc.
 Aristea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aristea Therapeutics, Inc. operates as a clinical-stage drug development company. It develops novel therapies to treat serious inflammatory diseases. The company was founded by James Morrison MacKay in 2018 and is headquartered in Poway, CA. | Direktor/Vorstandsmitglied | 01.11.2019 |
Zehna Therapeutics, Inc.
 Zehna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Zehna Therapeutics, Inc. develops non-bactericidal inhibitors for cardiovascular and chronic kidney diseases. The company is based in Cleveland, OH. | Vorstandsvorsitzender | 01.04.2021 |
Ehemalige bekannte Positionen von Camilla Simpson
| Unternehmen | Position | Ende |
|---|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Corporate Officer/Principal | 01.04.2019 |
| GRI BIOPAR | Direktor/Vorstandsmitglied | - |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | General Counsel | - |
Ausbildung von Camilla Simpson
| Kingston University | Undergraduate Degree |
| National University of Ireland Galway | Undergraduate Degree |
| University of London | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Health Technology |
| SPRUCE BIOSCIENCES, INC. | Health Technology |
| Private Unternehmen | 7 |
|---|---|
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Health Technology |
| Rare Strategic LLC | |
Dyve Biosciences, Inc.
Dyve Biosciences, Inc. BiotechnologyHealth Technology Dyve Biosciences, Inc. operates as a research and development company. It focuses on biotech that creates novel therapeutics using proprietary science. The company was founded by Ryan Beal and Rajit Malhotra and is headquartered in Thousand Oaks, CA. | Health Technology |
Aristea Therapeutics, Inc.
Aristea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aristea Therapeutics, Inc. operates as a clinical-stage drug development company. It develops novel therapies to treat serious inflammatory diseases. The company was founded by James Morrison MacKay in 2018 and is headquartered in Poway, CA. | Health Technology |
Zehna Therapeutics, Inc.
Zehna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Zehna Therapeutics, Inc. develops non-bactericidal inhibitors for cardiovascular and chronic kidney diseases. The company is based in Cleveland, OH. | Health Technology |
Vallon Pharmaceuticals, Inc.
 Vallon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Vallon Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on the development and commercialization of proprietary biopharmaceutical products. The firm's primary product is Abuse-Deterrent Amphetamine Immediate and its product pipeline includes ADAIR, ADMIR, ADHD, and Narcolepsy. The company was founded by David C. Baker on January 11, 2018 and is headquartered in Philadelphia, PA. | Health Technology |
| GRI Bio, Inc. |
